Health Condition 1: null- â?¢ All patients belonging to American society of Anesthesiologists physical status grade I and II â?¢ Age between 18 to 60 years.
Conditions
Interventions
Intervention1: Group 2(RT1): Wound infiltration with 17 ml of ropivacaine 0.75% + tramadol 1 mg/kg.
Intervention2: Group 3(RT2): Wound infiltration with 17 ml of ropivacaine 0.75 % + tramadol 2 mg/kg.
Sponsors
Sri Venkateswara Institute of Medical Sciences
Eligibility
Inclusion criteria
Inclusion criteria: 1)All patients belonging to American society of Anesthesiologists physical status grade I and II 2)Age between 18 to 60 years.
Exclusion criteria
Exclusion criteria: 1)Allergy to any of study drugs. 2)Patients on treatment with chronic opioids or study drugs. 3)Who have cardiovascular, pulmonary, renal, neurological and metabolic diseases. 4)Inability to comprehend numerical rating scale. 5)Who undergo cervical spine surgeries. 6)Patients unwilling to participate in the study. 7)Pregnant and lactating mothers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome variable will be determined as the time to first analgesic administration by recording numerical rating scale every hour postoperatively after infiltration of the study drug.Timepoint: Time frame 24 hours after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Any adverse effects observed with ropivacaine and tramadol will be determined as secondary outcomeTimepoint: Time frame 24 hours after surgery | — |
Countries
India
Contacts
Public ContactAloka Samantaray
Sri Venkateswara institute of Medical Sciences
Outcome results
None listed